An Irish firm whose product will be central in the fight against antibiotic-resistant superbugs last week received a €1.5m investment to underpin its plans for global expansion.

Ten years after starting its search for an effective antimicrobial coating, the Dublin firm will launch its weapon against bacteria, writes Trish Dromey.